Plasma cancer biomarker multiplex screening and the risk of subsequent preeclampsia Margarita L. Martinez-Fierro, Idalia Garza-Veloz, Claudia Castruita-Dela Rosa, Yolanda Ortiz-Castro, Maria C. Aceves-Medina, Rosbel Vazquez-Castro, Ivan Delgado-Enciso, Maria E. Castañeda-Lopez International Journal of Cardiology Volume 179, Pages 58-60 (January 2015) DOI: 10.1016/j.ijcard.2014.10.168 Copyright © 2014 The Authors Terms and Conditions
Fig. 1 Concentration data of the significant markers at the four pregnancy time points. Pregnancies were classified as WPD-PE or as pregnancies without complications, and the concentrations (pg/ml) of each marker were compared between the groups at each time point. The figure shows the results obtained for FGF-basic, sHER2/neu, sIL-6α, uPA, endoglin, and IGFBP-1. For the WPD-PE, a set of 15 samples at the time of the PE diagnosis was included in the plot; this sample set was not available for the controls. International Journal of Cardiology 2015 179, 58-60DOI: (10.1016/j.ijcard.2014.10.168) Copyright © 2014 The Authors Terms and Conditions